Here are five takeaways:
1. Prevalence of spinal disorders, development of technologically advanced spinal devices, aging population and demand for minimally invasive spine surgery are all driving the spinal implants and devices market.
2. Regulatory guidelines, high costs and lack of reimbursements in developing countries limit the growth of the market.
3. North America is expected to continue dominating the market, followed by Europe.
4. The Asia-Pacific market is expected to grow the fastest at a CAGR of 8.2 percent. Rising healthcare expenditure, increasing government funding and a growing awareness of spinal devices will push this growth.
5. Medtronic, DePuy Synthes, Stryker, NuVasive, Zimmer Biomet, Globus Medical, Alphatec, Orhtofix International, K2M and LDR lead the market.
More articles on devices:
Medacta achieves milestones in 2015: 5 key notes
Zimmer Biomet, Lima strike a deal for Japanese market rights: 5 key notes
Vycor Medical to present new VBAS product line extension: 5 things to know
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
